Clinical Trials
21 trialsNCT07609030 2026-05-27
A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma
Ohio State University Comprehensive Cancer Center
Phase NA Recruiting
NCT06693830 2026-01-23
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Columbia University
Phase NA Recruiting
NCT07345741 2026-01-16
Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Tongji Hospital
Phase NA Not yet recruiting
NCT06744075 2025-12-30
CELERITY
Centre Henri Becquerel
Phase NA Active not recruiting
NCT06004167 2025-12-09
Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)
Massachusetts General Hospital
Phase NA Completed
NCT05556239 2025-12-08
STAY-STRONG
Rigshospitalet, Denmark
Phase NA Completed
NCT06485076 2025-12-03
EPC-MM+L
University Health Network, Toronto
Phase NA Recruiting
NCT05940272 2025-10-09
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT06866873 2025-03-10
CD-19 CAR-T Cell for Pediatric ALL or Lymphoma
Hong Kong Children's Hospital
Phase NA Recruiting
NCT06850285 2025-02-27
CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
Shanxi Bethune Hospital
Phase NA Recruiting
NCT04097067 2024-08-27
ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma
University Hospital Muenster
Phase NA Recruiting
NCT05510596 2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA Completed
NCT05376709 2023-07-27
A Mixed Methods Study of Nutrition Practice in Cancer Care on Non-Hodgkin Lymphoma Population
National Taiwan University Hospital
Phase NA Unknown
NCT05797948 2023-04-04
GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University
Phase NA Unknown
NCT03787056 2021-07-16
ONCOPRO
Hospices Civils de Lyon
Phase NA Recruiting
NCT03302403 2020-10-08
Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors
First Affiliated Hospital of Wenzhou Medical University
Phase NA Unknown
NCT00038883 2018-11-07
Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies
M.D. Anderson Cancer Center
Phase NA Terminated
NCT03564977 2018-07-02
CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation
Qingdao Central Hospital
Phase NA Unknown
NCT01541072 2016-11-01
PALM2
Centre Leon Berard
Phase NA Terminated
NCT02813837 2016-06-28
Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies
Innovative Cellular Therapeutics Co., Ltd.
Phase NA Unknown
NCT01044004 2013-07-23
Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue
Washington University School of Medicine
Phase NA Withdrawn